Entry Point Capital, LLC Veracyte, Inc. Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
A detailed history of Entry Point Capital, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 4,245 shares of VCYT stock, worth $158,508. This represents 0.13% of its overall portfolio holdings.
Number of Shares
4,245
Previous 10,188
58.33%
Holding current value
$158,508
Previous $226 Million
59.25%
% of portfolio
0.13%
Previous 0.2%
Shares
3 transactions
Others Institutions Holding VCYT
# of Institutions
270Shares Held
78.7MCall Options Held
42.3KPut Options Held
18.2K-
Black Rock Inc. New York, NY7.79MShares$291 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.5MShares$280 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA6.88MShares$257 Million0.03% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$184 Million1.59% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT3.17MShares$118 Million0.44% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.67B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...